Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SIBN | US
0.01
0.08%
Healthcare
Medical Devices
30/06/2024
18/03/2026
12.85
13.00
13.15
12.65
SI-BONE Inc. a medical device company develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion adult deformity and degeneration and pelvic trauma. The company also provides iFuse-3D a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force as well as through agents and distributors. SI-BONE Inc. was incorporated in 2008 and is headquartered in Santa Clara California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
37.0%1 month
39.7%3 months
41.5%6 months
46.2%-
-
3.36
0.24
0.18
-14.15
2.92
-
-40.61M
535.77M
535.77M
-
-25.22
-
20.00
-23.88
5.99
4.62
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.75
Range1M
4.23
Range3M
9.24
Rel. volume
0.94
Price X volume
7.75M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Bioventus Inc. | BVS | Medical Devices | 8.92 | 581.47M | -0.78% | n/a | 261.56% |
| Cytek Biosciences Inc. Common Stock | CTKB | Medical Devices | 4.34 | 570.74M | 2.12% | n/a | 8.53% |
| Embecta Corp | EMBC | Medical Instruments & Supplies | 8.86 | 511.24M | -0.56% | 11.37 | -216.41% |
| Orthofix International N.V | OFIX | Medical Devices | 11.86 | 452.75M | -1.41% | n/a | 28.63% |
| AngioDynamics Inc | ANGO | Medical Instruments & Supplies | 10.4 | 422.60M | -2.89% | n/a | 2.44% |
| OrthoPediatrics Corp | KIDS | Medical Devices | 16.66 | 403.41M | -3.20% | n/a | 3.67% |
| Neuropace Inc. Common Stock | NPCE | Medical Devices | 13.56 | 395.91M | -1.88% | n/a | 745.17% |
| Common Stock | VMD | Medical Devices | 9.32 | 361.86M | -3.82% | 39.96 | 10.44% |
| JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares | ZJYL | Medical Instruments & Supplies | 2.25 | 352.23M | -4.26% | 115.00 | 36.89% |
| Perspective Therapeutics Inc. | CATX | Medical Devices | 4.86 | 327.70M | -1.82% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Ennis Inc | EBF | Building Products & Equipment | 20.44 | 531.52M | -2.20% | 13.28 | 2.28% |
| The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 2.4 | 474.61M | -3.61% | n/a | 0.00% |
| FRP Holdings Inc | FRPH | Real Estate Services | 21.285 | 405.06M | -4.55% | 75.50 | 42.65% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.06 | 293.14M | -4.67% | n/a | 174.23% |
| Urban One Inc | UONEK | Broadcasting - Radio | 5.4 | 286.24M | -4.42% | n/a | 268.43% |
| The RMR Group Inc | RMR | Real Estate Services | 15.79 | 264.08M | -2.47% | 16.64 | 14.14% |
| RE/MAX Holdings Inc | RMAX | Real Estate Services | 6.02 | 189.13M | 0.67% | n/a | 114.28% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 13.93 | 155.43M | -3.60% | 15.61 | -621.78% |
| Comstock Holding Companies Inc | CHCI | Real Estate Services | 15.22 | 150.10M | 6.36% | 14.10 | 17.12% |
| Douglas Elliman Inc. | DOUG | Real Estate Services | 1.6 | 146.93M | -3.61% | n/a | 62.82% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -14.15 | - | Cheaper |
| Ent. to Revenue | 2.92 | - | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 3.36 | 6.21 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 41.54 | - | Lower Risk |
| Debt to Equity | 0.24 | -145.53 | Expensive |
| Debt to Assets | 0.18 | 0.35 | Cheaper |
| Market Cap | 535.77M | - | Emerging |